Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamivudine prophylaxis during adjuvant chemoradiotherapy in HBV carrier patients after gastrectomy
ChiCTR-TRC-12002121Phase 3Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of lamivudine in hepatitis B (HBV) and gastric adenocarcinoma (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Liver function. Started Apr 2012; status: completed.
02
Drugs
lamivudine
03
Conditions
hepatitis B (HBV)gastric adenocarcinoma
Beyond the preview
Go deeper on ChiCTR-TRC-12002121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002121.